Congratulations to Mirxes on its successful listing on the Hong Kong Stock Exchange's Main Board — Gaorong Ventures was its earliest institutional investor.
A leading provider of molecular cancer screening products and services.
高榕创投
@gaorong
创造美好生活
531 articles
Articles
Rongbao | Multiple Products Debut at Shanghai Auto Show, AI Drug Lands Major Licensing Deal, Mingming Henmang and Geekplus Race Toward Hong Kong IPOs
New product launches, major licensing deals, accelerated clinical trials...
CDM Leader "CloudXinda" Closes Tens of Millions in Funding, Unlocking the Backup Data Gold Mine in the AI Era | Gaorong Future
The Data Foundation for the AI Era
A Conversation with Aozhe, the Leading Low-Code Platform, on the Two-Way Street Between Low-Code and AI | Gaorong Future
All-in-one low-code platforms are fully integrating AI capabilities.
Smart Glasses Take Off: How Leiyu Pushes Full-Color Micro-LED Micro-Displays to the Limit to Light Up AR's Infinite Possibilities | Gaorong Future
The world's smallest full-color Micro-LED optical engine lights the spark for a "visual revolution" in smart glasses.
How Is DeepSeek Revolutionizing AI Application Development? 34 Insights from 7 Practitioners | Ronghui
From consumer-facing apps to vertical domains like travel, finance, and healthcare, and on to AI agents.
Rongbao | Generative AI and medical device companies close new funding rounds, setting domestic records in their respective sectors
The Power of Aspiration.
Pulnovo Medical closes nearly $100 million Series C, setting a new Asia-Pacific record for medical device financing
A pioneer in China's original medical device innovation.
LiblibAI Secures Another Round of Hundreds of Millions of RMB in Funding, Advancing Toward the World's Largest AI Content Creation and Consumption Platform
Expand the platform's reach globally.
Kailan Pharma Closes Oversubscribed A+ Round of Over 100 Million RMB to Advance Cholesterol Metabolism Drug R&D
Striving to provide alternative treatment options for patients with metabolic diseases.